Skip to content
Wednesday, 4 November 2026
Inspire.News

Unveiling truth, one story at a time

Cerus (CERS) Q3 2026 Earnings Call Transcript

REDeS trial met efficacy endpoints; ISC revenue surged 44% year over year.

Full story

Continue reading this story on The Motley Fool, the publisher that reported it.

Read the full story at The Motley Fool ↗

AI tools

Written by AI from the article text. It can make mistakes; check the original story.

Topics in this story

More from Business

See all